However, other EBV-positive cells (Akata, P3HR-1, and Mutu-1 Burkitt lymphoma cells) that expressed low levels of NF-κB and no detectable LMP-1 were much less sensitive to simvastatin. This evidence concerns the gene PDLIM7 and Burkitt lymphoma.